High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
about
Current and Emerging Applications of Droplet Digital PCR in Oncology.Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancerExtracellular Vesicles Arising from Apoptotic Cells in Tumors: Roles in Cancer Pathogenesis and Potential Clinical Applications.New Technologies for Analysis of Extracellular Vesicles.Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers.Discovery of Double-Stranded Genomic DNA in Circulating Exosomes.Understanding Disease Biology and Informing the Management of Pancreas Cancer With Preclinical Model Systems.Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients.Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer.Liquid biopsy in pancreatic cancer: the beginning of a new era.Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics.The Significance of Liquid Biopsy in Pancreatic CancerLarge extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasmaLiquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)The Role of Extracellular Vesicles in Cancer: Cargo, Function, and Therapeutic Implications
P2860
Q38374623-ECCDF991-C79B-4C44-BAEA-6017A64CA558Q42360040-44A06621-A990-4505-A352-AA61DFE8CC4DQ42364533-162AA38C-D13B-4279-BB21-E78A0C3AF44BQ48135155-4A88CB8D-E96A-4085-976F-B6A2722B91E2Q48527971-BFD6988C-4AC6-428D-BA83-C4ADFD27C6C8Q48528638-D8717579-3168-4CD6-8B49-8894025CAA6AQ49494945-3D67B7E3-4813-43E9-9893-5466956E38AAQ49645159-2D8570DD-DDD6-4C73-92EF-F05B476353BDQ49889746-2B7504CC-568C-4D47-B4FF-AF497D85E75DQ49966087-E5953833-B542-493A-B6C8-A6485E4C0875Q52595056-DF0C656F-F342-417D-AD37-7EB1B262DFBEQ52739894-4AABCBDD-1B4E-4FA8-95D5-8D8EBF2D7EC5Q55021702-94C436BA-9A31-445A-975D-B520847369EEQ55187959-292FEED1-5F61-454B-B23A-E058957EDB16Q55253817-6D4D19A9-96A0-4158-A439-8E1AAB6BB6DCQ57116278-3A0607CA-797E-49FB-9445-1FD26F6C0F7CQ58797453-7DB5ECAD-2E30-49AA-A12F-C559FDCA7F4DQ58799160-20D503D4-A9E4-4350-B299-9AE443233D6FQ58805122-38DB1CD6-02F2-4A0F-920E-3351FBF66E6B
P2860
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
High prevalence of mutant KRAS ...... ge pancreatic cancer patients.
@en
type
label
High prevalence of mutant KRAS ...... ge pancreatic cancer patients.
@en
prefLabel
High prevalence of mutant KRAS ...... ge pancreatic cancer patients.
@en
P2093
P2860
P50
P356
P1433
P1476
High prevalence of mutant KRAS ...... ge pancreatic cancer patients.
@en
P2093
F A San Lucas
F Meric-Bernstam
G Varadhachary
P2860
P304
P356
10.1093/ANNONC/MDX004
P577
2017-04-01T00:00:00Z